QMB Kidney Programme

Download the meeting schedule as a PDF.

Programme (9.00 am - 5.30 pm each day)

Sunday 29th August

• Peter Deen, University of Rabdoud, Nijmegen, The Netherlands
  Vasopressin type-2 receptor mutants in Nephrogenic diabetes insipidus:correction by pharmacological chaperones?

Transporters and Renal Physiology

• Stefan Bröer, Australian National University, Australia
  Transport metabolons in the apical membrane
• Dan Markovich, University of Queensland, Australia
  The Sat1 Anion Transporter (Slc26a1) and Calcium Oxalate Urolithiasis
• Heddwen Brooks, University of Arizona, USA
  Novel mechanisms of vasopressin action: role in renal function and disease

Renal Fibrosis and Inflammation

• Tim Hewitson, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
  The kidney and fibrosis- Just say NO
• Phil Poronnik, RMIT University, Australia
  Molecular mechanisms of albuminaria - beyond the podocyte
• David Nikolic-Paterson, Monash University, Australia
  TGFß1-activated kinase (TAK1) in phagocytes and podocytes modulates the development of  albuminaria 
• Greg Tesch, Monash University, Australia
  Albuminuria in diabetic nephropathy - role of lymphocytes and macrophages
• David Harris, University of Sydney, Australia
  Anti-inflammatory macrophages in renal diseas
• Greg Jones, University of Otago, New Zealand
  Matrix Metalloproteinases in Vascular Remodelling, the critical role of assessing activity over total protein levels

Dinner at Gantleys 7.00 pm

Monday 20th August

• Moo Kwon, Departments of Medicine and Physiology, University of Maryland, USA
  The transcription factor TonEBP in inflammation and kidney disease

Biomarkers for renal disease

• Hans Peter Marti, University of Bern, Bern, Switzerland
  Defining novel biomarkers in kidney transplantation
• Glenda Gobe, University of Queensland, Australia
  Mitochondrial dysregulation in chronic kidney disease: where structure meets function

Open session including posters

Website design by Webcentre Ltd